COPN — Cosmo Pharmaceuticals NV Cashflow Statement
0.000.00%
- CH₣1.05bn
- CH₣937.33m
- €266.79m
- 88
- 34
- 78
- 79
Annual cashflow statement for Cosmo Pharmaceuticals NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.93 | 24 | 24.5 | -6.97 | 153 |
| Depreciation | |||||
| Non-Cash Items | 16.1 | -11.1 | 10.2 | 16.9 | 4.12 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.27 | -7.7 | -15.3 | 0.909 | -7.36 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 13 | 12.6 | 33.2 | 22.7 | 162 |
| Capital Expenditures | -8.09 | -8.5 | -7.31 | -4.4 | -5.65 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 83.5 | 33.4 | 9 | 57.6 | -123 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 75.4 | 24.9 | 1.69 | 53.2 | -129 |
| Financing Cash Flow Items | -4.38 | -4.88 | -4.38 | -6.38 | -4.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -11.9 | -27.2 | -46.1 | -211 | -40.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 75.5 | 12.6 | -12.7 | -136 | -5.98 |